University of Connecticut

Events Calendar

Dermatology Grand Rounds Via Mediasite Link

Wednesday, June 3, 2020
8:00am – 9:00am

UConn Health
Media Site

"COVID-19: What Clinical Dermatologists Should Know”

Provided by University of Connecticut School of Medicine Office of Community and Continuing Medical Education and the Department of Dermatology

Speakers: Michael Storonsky, MD, Chief Resident, PGY4 – UConn Dermatology (Diane Whitaker-Worth, MD to oversee presentation lecture) Date: Wednesday, June 3, 2020 Time: 8am – 9am Location: Media Site Video Conferencing Link:

Target Audience: UCHC dermatologists and dermatology residents. All other podiatrists, nurses, nurse practitioners, residents, students, and greater Hartford dermatologists are encouraged to attend.

Objectives: Participants will (be able to):

a. Recite the evidence or expert opinion associated with the dermatological manifestations and medical dermatology management of patients with Covid-19.

b. Identify cutaneous manifestations of Covid-19 that may otherwise mimic other dermatological conditions leading to a barrier or delay in diagnosis of Covid-19 patients.

c. Describe one or more strategies necessary to identify which patients clinicians may begin or continue immunosuppressive dermatological medications depending on their Covid-19 status, exposure and medications history.

Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Connecticut School of Medicine designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.

Neither the activity director, planning committee members, nor the speaker, Dr. Storonsky, have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.

Dr. Storonsky will be discussing the off-labeled use of Ivermectin, Hydroxycloroqine and potentially other new and emerging COVID-19 treatments.

This CME activity has no commercial support associated with it.

Evaluations: Participants are required to complete an electronic evaluation in order to obtain CME Credits. An email from with instructions will be sent to participants. Please complete the evaluation within one week of


Diane Whitaker-Worth, MD -

Continuing Medical Education (primary), UConn Master Calendar

Control Panel